PPARG and endothelial dysfunction: Previous clinical studies have demonstrated that partial PPAR-γ agonist (ARBs) protects vascular endothelium via an increase of endothelial NO synthesis [82] and plasma adiponectin concentration [57] thus preventing endothelial dysfunction more effectively as compared to non-PPAR-γ agonists ARBs [83].